TransMedics Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of TransMedics Group generated cash of -$13,028,000, which is more than the previous year. Cash used in financing activities reached the amount of $400,418,000 last year. Net change in cash is therefore $193,630,000.
Cash Flow
| 2016 | -24.10M | -39.67M | 63.54M |
|---|---|---|---|
| 2017 | -23.09M | 24.85M | 3K |
| 2018 | -25.98M | 12.30M | 22.06M |
| 2019 | -32.28M | -60.50M | 92.72M |
| 2020 | -30.26M | -41.59M | 75.54M |
| 2021 | -28.86M | 29.26M | 1.39M |
| 2022 | -45.81M | 54.51M | 167.92M |
| 2023 | -13.02M | -193.95M | 400.41M |
TMDX Cash Flow Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 201.68M | 26.08M | 25.08M | 20.59M | 20.74M | 12.43M | 10.33M | 10.58M |
Operating activities | ||||||||
Net income | -25.02M | -36.23M | -44.21M | -28.74M | -33.54M | -23.75M | -20.82M | -24.06M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 8.17M | 3.47M | 1.81M | 1.57M | 1.22M | 769K | 630K | 426K |
Stock-based compensation expense | 19.79M | 10.32M | 6.87M | 2.41M | 854K | 144K | 70K | 45K |
| Deferred income tax benefit | 19.79M | 10.32M | 6.87M | 2.41M | 854K | 144K | 70K | 45K |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | -33.81M | -21.67M | 840K | -218K | -3.16M | -2.51M | 454K | -758K |
Inventories | -28.09M | -8.02M | -4.89M | -1.74M | -4.12M | -2.69M | -2.49M | -1.58M |
Accounts payable | 6.95M | -3.27M | 5.09M | -5.80M | 3.44M | 164K | -735K | 1.06M |
Cash generated by operating activities | -13.02M | -45.81M | -28.86M | -30.26M | -32.28M | -25.98M | -23.09M | -24.10M |
Investing activities | ||||||||
Purchases Of Investments | 0 | -10.49M | -72.02M | -121.79M | -82.37M | 0 | -19.18M | -46.53M |
Investments In Property Plant And Equipment | -151.84M | -11.90M | -3.51M | -455K | -165K | -418K | -263K | -1.47M |
Acquisitions Net | -14.89M | 107K | -32.78M | 41.14M | 60.33M | 0 | 0 | 0 |
Cash generated by investing activities | -193.95M | 54.51M | 29.26M | -41.59M | -60.50M | 12.30M | 24.85M | -39.67M |
Financing activities | ||||||||
Common Stock Issued | 0 | 139.85M | 1.39M | 75.54M | 97.36M | 46K | 3K | 63.62M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 955K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 445.38M | 22.45M | 0 | -2.24M | 0 | -9.07M | 0 | 0 |
Cash used in financing activities | 400.41M | 167.92M | 1.39M | 75.54M | 92.72M | 22.06M | 3K | 63.54M |
Net Change In Cash | 193.63M | 175.60M | 999K | 4.48M | -149K | 8.30M | 2.09M | -243K |
Cash at end of period | 395.31M | 201.68M | 26.08M | 25.08M | 20.59M | 20.74M | 12.43M | 10.33M |
| Data source | Data source | Data source | Data source | Data source |